Literature DB >> 11395383

Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions.

J S Liu1, M L Zhao, C F Brosnan, S C Lee.   

Abstract

Nitric oxide generated by the inducible form of nitric oxide synthase (iNOS) may contribute to the pathogenesis of multiple sclerosis (MS). In this report, we studied postmortem tissues of MS patients for the expression of iNOS by in situ hybridization and immunocytochemistry. Immunocytochemistry for nitrotyrosine, a putative footprint for peroxynitrite formation was also performed. In acute MS lesions, intense reactivity for iNOS mRNA and protein was detected in reactive astrocytes throughout the lesion and in adjacent normal appearing white matter. Staining of macrophages, inflammatory cell infiltrates, and endothelial cells was variable from case to case, but generally detected only in acute lesions. In chronic MS lesions reactive astrocytes at the lesion edge were positive for iNOS whereas the lesion center was nonreactive. Normal appearing white matter demonstrated little reactivity, as did tissues from noninflamed control brains. Staining for nitrotyrosine was also detected in acute but not chronic MS lesions, and displayed a diffuse parenchymal, membranous, and perivascular pattern of immunoreactivity. These results support the conclusion that iNOS is induced in multiple cell types in MS lesions and that astrocyte-derived nitric oxide could be important in orchestrating inflammatory responses in MS, particularly at the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11395383      PMCID: PMC1891989          DOI: 10.1016/S0002-9440(10)64677-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

Review 1.  Nitric oxide synthases: roles, tolls, and controls.

Authors:  C Nathan; Q W Xie
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

Review 2.  Regulation of biosynthesis of nitric oxide.

Authors:  C Nathan; Q W Xie
Journal:  J Biol Chem       Date:  1994-05-13       Impact factor: 5.157

3.  A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis.

Authors:  A H Cross; M San; M K Stern; R M Keeling; D Salvemini; T P Misko
Journal:  J Neuroimmunol       Date:  2000-07-10       Impact factor: 3.478

4.  Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-alpha.

Authors:  M Downen; T D Amaral; L L Hua; M L Zhao; S C Lee
Journal:  Glia       Date:  1999-11       Impact factor: 7.452

5.  Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction.

Authors:  N C O'Brien; B Charlton; W B Cowden; D O Willenborg
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

6.  NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease.

Authors:  M Hesse; A W Cheever; D Jankovic; T A Wynn
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

Review 7.  Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review.

Authors:  D O Willenborg; M A Staykova; W B Cowden
Journal:  J Neuroimmunol       Date:  1999-12       Impact factor: 3.478

8.  Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes.

Authors:  D A Geller; C J Lowenstein; R A Shapiro; A K Nussler; M Di Silvio; S C Wang; D K Nakayama; R L Simmons; S H Snyder; T R Billiar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma.

Authors:  S C Lee; D W Dickson; W Liu; C F Brosnan
Journal:  J Neuroimmunol       Date:  1993-07       Impact factor: 3.478

10.  A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.

Authors:  S A Lipton; Y B Choi; Z H Pan; S Z Lei; H S Chen; N J Sucher; J Loscalzo; D J Singel; J S Stamler
Journal:  Nature       Date:  1993-08-12       Impact factor: 49.962

View more
  99 in total

Review 1.  Statins as potential therapeutic agents in multiple sclerosis.

Authors:  Olaf Stüve; Thomas Prod'homme; Sawsan Youssef; Shannon Dunn; Oliver Neuhaus; Martin Weber; Hans-Peter Hartung; Lawrence Steinman; Scott S Zamvil
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

2.  Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155*.

Authors:  Leonid Tarassishin; Olivier Loudig; Avital Bauman; Bridget Shafit-Zagardo; Hyeon-Sook Suh; Sunhee C Lee
Journal:  Glia       Date:  2011-12       Impact factor: 7.452

Review 3.  Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Prog Neurobiol       Date:  2010-10-12       Impact factor: 11.685

Review 4.  Control of autoimmune CNS inflammation by astrocytes.

Authors:  Veit Rothhammer; Francisco J Quintana
Journal:  Semin Immunopathol       Date:  2015-07-30       Impact factor: 9.623

5.  LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14.

Authors:  Leonid Tarassishin; Hyeon-Sook Suh; Sunhee C Lee
Journal:  Glia       Date:  2014-03-21       Impact factor: 7.452

6.  Atm-deficient mice exhibit increased sensitivity to dextran sulfate sodium-induced colitis characterized by elevated DNA damage and persistent immune activation.

Authors:  Aya M Westbrook; Robert H Schiestl
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

Review 7.  Nitric oxide and multiple sclerosis.

Authors:  Juan Manuel Encinas; Louis Manganas; Grigori Enikolopov
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

8.  Evidence of nitrosative damage in the brain white matter of patients with multiple sclerosis.

Authors:  Oscar A Bizzozero; Gisela DeJesus; Heather A Bixler; Andrzej Pastuszyn
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

9.  Nrf2 Signaling in Sodium Azide-Treated Oligodendrocytes Restores Mitochondrial Functions.

Authors:  Annette Liessem-Schmitz; Nico Teske; Miriam Scheld; Stella Nyamoya; Adib Zendedel; Cordian Beyer; Tim Clarner; Athanassios Fragoulis
Journal:  J Mol Neurosci       Date:  2018-08-23       Impact factor: 3.444

Review 10.  Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria.

Authors:  Guy C Brown; Anna Bal-Price
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.